Management of Perimenopause Symptoms

Pharmacologic Treatment Options

• The American College of Obstetricians and Gynecologists recommends menopausal hormone therapy (MHT) as the most effective treatment for vasomotor symptoms in perimenopause, with estradiol as the typical starting dose 1, 2, 3
• SNRIs (e.g., venlafaxine) and SSRIs have demonstrated efficacy in reducing hot flashes and are first-line non-hormonal options, according to the National Comprehensive Cancer Network 1, 6
• Gabapentin is effective for reducing hot flashes and may be particularly useful at bedtime due to its sedating effects, as noted by the Journal of Clinical Oncology 1, 6
• Clonidine (antihypertensive) has shown some benefit for vasomotor symptoms but with limited efficacy, according to the Annals of Oncology 2, 7
• For vaginal symptoms, non-hormonal water-based lubricants and moisturizers are first-line treatments, as recommended by the Ca-A Cancer Journal for Clinicians 3
• MHT carries risks that must be weighed against benefits, including increased risk of stroke, pulmonary embolism, and possibly breast cancer (with estrogen plus progestin), as reported by the Journal of the National Comprehensive Cancer Network 4, 5

Non-Pharmacologic Approaches

• Weight loss of ≥10% of body weight may help eliminate hot flash symptoms in overweight women, according to the Journal of the National Comprehensive Cancer Network 4, 5
• Smoking cessation can improve the frequency and severity of hot flashes, as noted by the Journal of the National Comprehensive Cancer Network 5
• Limiting alcohol intake may help if it triggers hot flashes in individual women, as recommended by the Journal of the National Comprehensive Cancer Network 5
• Environmental modifications such as dressing in layers, keeping rooms cool, and using cold packs can help manage hot flashes, according to the Annals of Oncology 8, 9
• Identifying and avoiding personal hot flash triggers (spicy foods, caffeine, stress) through a hot flash diary can be helpful, as suggested by the Annals of Oncology 8, 7
• Cognitive behavioral therapy (CBT) has been shown to reduce the perceived burden of hot flashes, according to the Journal of the National Comprehensive Cancer Network 4, 5
• Acupuncture has demonstrated efficacy in reducing menopausal symptoms and hot flashes in some studies, as reported by the Journal of Clinical Oncology and the Journal of the National Comprehensive Cancer Network 2, 6
• Regular physical activity should be recommended for overall health benefits, though evidence for direct impact on vasomotor symptoms is limited, as noted by the Journal of the National Comprehensive Cancer Network 4, 5
• Yoga may improve quality of life associated with menopause, including vasomotor symptoms, according to the Journal of the National Comprehensive Cancer Network 6

Treatment Algorithm Based on Symptom Severity

• For women without contraindications to hormonal therapy, MHT (estradiol 1-2 mg daily with appropriate progestin if uterus is intact) may be considered, as recommended by the Journal of Clinical Oncology and the Journal of the National Comprehensive Cancer Network 1, 2, 6
• For women with contraindications to hormonal therapy or who prefer non-hormonal options, SNRIs (e.g., venlafaxine) or SSRIs may be considered, as noted by the Annals of Oncology and the Journal of the National Comprehensive Cancer Network 7, 6
• For genitourinary symptoms, non-hormonal vaginal moisturizers and lubricants are first-line treatments, as recommended by the Ca-A Cancer Journal for Clinicians 3

Important Considerations and Caveats

• Treatment should be tailored based on symptom severity, impact on quality of life, and presence of contraindications, as noted by the Annals of Oncology 8
• Women with a history of breast cancer require special consideration, with non-hormonal options being preferred, according to the Journal of Clinical Oncology 1, 2